Follicular fluid proteomic alterations associated with oocyte developmental potential in polycystic ovary syndrome
-
By
-
April 16, 2026
Objective:
To characterize the proteomic landscape of follicular fluid (FF) in patients with PCOS and identify potential biomarkers for oocyte quality assessment, which may improve clinical outcomes.
Key Findings:
- Normal fertilization rate in PCOS patients was significantly lower than in controls after adjusting for age, BMI, and infertility duration, indicating a need for targeted interventions.
- Identified 11 upregulated and 17 downregulated differentially expressed proteins (DEPs) in the PCOS group, with implications for understanding oocyte quality.
- Notably, VNN1 was upregulated, while PLTP and HYOU1 were downregulated in PCOS FF, suggesting potential targets for therapeutic strategies.
- DEPs were significantly enriched in cholesterol metabolism, indicating a link to oocyte quality and potential metabolic interventions.
Interpretation:
The distinct proteomic signature in PCOS FF, characterized by altered lipid metabolism and stress responses, suggests a mechanistic link to impaired oocyte competence, which may inform future clinical practices.
Limitations:
- The study may not account for all variables influencing oocyte quality, such as hormonal levels and environmental factors.
- Further research is needed to establish causative relationships between identified proteins and oocyte development, particularly in diverse populations.
Conclusion:
The findings highlight the importance of proteomic profiling in understanding the microenvironment of oocytes in PCOS, potentially guiding future therapeutic strategies such as targeted nutritional or pharmacological interventions.
